Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
B lymphocyte chemoattractant, independently cloned and named Angie, is a CXC chemokine strongly expressed in the follicles of the spleen, lymph nodes, and Peyer's patches. Additionally we are shipping CXCL13 Proteins (41) and CXCL13 Kits (25) and many more products for this protein.
Showing 10 out of 115 products:
Human Monoclonal CXCL13 Primary Antibody for ELISA (Capture), FACS - ABIN4899778
Klimatcheva, Pandina, Reilly, Torno, Bussler, Scrivens, Jonason, Mallow, Doherty, Paris, Smith, Zauderer: CXCL13 antibody for the treatment of autoimmune disorders. in BMC immunology 2015
Show all 6 references for ABIN4899778
Human Polyclonal CXCL13 Primary Antibody for IF (p), IHC (p) - ABIN741960
Pei, Zeng, Han, Liao, Zhou, Li, Zhang, Liu, Zhang, Liu, Yao, Xu: Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy. in Clinical journal of the American Society of Nephrology : CJASN 2014
Show all 4 references for ABIN741960
Mouse (Murine) Polyclonal CXCL13 Primary Antibody for IF (p), IHC (p) - ABIN706691
Siepert, Brösel, Vogt, Ahrlich, Schmitt-Knosalla, Loddenkemper, Kühl, Baumgrass, Gerstmayer, Tomiuk, Tiedge, Viklický, Brabcova, Nizze, Lehmann, Volk, Sawitzki: Mechanisms and Rescue Strategies of Calcineurin Inhibitor Mediated Tolerance Abrogation Induced by Anti-CD4 mAb Treatment. in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013
Show all 2 references for ABIN706691
Human Monoclonal CXCL13 Primary Antibody for FACS - ABIN4896649
Kobayashi, Watanabe, Suzuki, Furu, Ito, Ito, Matsuda, Yoshitomi: TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. in European journal of immunology 2016
Show all 2 references for ABIN4896649
Human Polyclonal CXCL13 Primary Antibody for IF (p) - ABIN892772
Nakamura, Ito, Kobayashi, Herndon, Suzuki: Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype. in Cytokine 2015
Data demonstrate that CXCL13 is not essential in mounting effective peripheral humoral responses, but specifically promotes CNS accumulation of differentiated B cells.
overexpression of CXCL13 is associated with myasthenia gravis.
Deficiency in Cxcl13 or its receptor, Cxcr5 (show CXCR5 Antibodies), significantly attenuated benzo(a)pyrene-induced lung cancer in mice, demonstrating CXCL13's critical role in polycyclic aromatic hydrocarbon-induced lung carcinogenesis.
Blockade of CXCL13 significantly reduced urine protein, serum creatinine, and dramatically attenuated renal pathology injury in lupus nephritis in mice.
Results from this study suggest blockade of CXCL13 and BAFFR (show TNFRSF13C Antibodies) together may be an effective therapeutic strategy in preventing salivary hypofunction and reducing autoantibody titers and sialadenitis in patients with Sjogren's syndrome
findings reveal a neuronal/astrocytic interaction in the spinal cord by which neuronally produced CXCL13 activates astrocytes via CXCR5 (show CXCR5 Antibodies) to facilitate neuropathic pain.
Study reports a novel role of AK141205/CXCL13 as a regulator of osteogenic growth peptide-induced osteogenic differentiation of smooth muscle cells.
Data indicate that CXC chemokine (show CXCL12 Antibodies) CXCL13-responsive late transitional B cells are the initiating subset for the positive feedback loop.
Study demonstrates that microglia are an important source of CXCL13 production in the acutely inflamed brain, and in vitro experiments confirm that type-I IFN selectively inhibits microglial production of CXCL13 in a dose-dependent manner
Data suggest that Src (show SRC Antibodies) homology 3 (SH3) protein interacting with NcK (show NCK1 Antibodies), 90 kDa (SPIN90 (show NCKIPSD Antibodies))plays an important role in B cell immune responses through the regulation of chemokine (show CCL1 Antibodies) CXCL13-mediated B cell migration.
CXCL13 could be a potential biomarker for predicting recurrence in HBV-related hepatocellular carcinoma patients after hepatectomy.
was overexpressed in pulmonary vascular lesions of patients with IPAH and CTEPH, and increased serum concentrations were found in patients with IPAH and CTEPH, suggesting a potential pathogenic role of CXCL13 in both diseases.
Findings suggest the potential use of chemokine (show CCL1 Antibodies) CXCL13 as a plasma biomarker of germinal centers (GCs (show GCLC Antibodies)) activity in vaccine trials and other clinical settings.
Aqueous humor concentration of CXCL13 is correlated with subfoveal choroidal thickness in normal subjects.
Serum CXCL10 (show CXCL10 Antibodies) and CXCL13 levels may serve as clinical markers and contribute to the inflammatory response, especially skin manifestations thereof, in adult-onset Still's disease
Gene encoding CXCL13 was identified as being upregulated and found to be negatively correlated with survival over 3-year follow-up period in Idiopathic pulmonary fibrosis.
Therefore, CSF CXCL13 concentrations could improve the diagnosis of ANS in HIV-infected patients
In the presence of endometriosis, proliferative-phase endometrial expression of CXCL13 markedly increased.
CXCL13 and CCL4 (show CCL4 Antibodies) could act as circulating biomarkers in autoimmune hemolytic anemia (AIHA), and higher plasma soluble TNFRII (show TNFRSF1B Antibodies) might favor the diagnosis of SLE-related instead of primary AIHA.
B lymphocyte chemoattractant, independently cloned and named Angie, is a CXC chemokine strongly expressed in the follicles of the spleen, lymph nodes, and Peyer's patches. It preferentially promotes the migration of B lymphocytes (compared to T cells and macrophages), apparently by stimulating calcium influx into, and chemotaxis of, cells expressing Burkitt's lymphoma receptor 1 (BLR-1). It may therefore function in the homing of B lymphocytes to follicles.
C-X-C motif chemokine 13
, B lymphocyte chemoattractant
, CXC chemokine BLC
, small inducible cytokine subfamily B (Cys-X-Cys), member 13
, small-inducible cytokine B13
, B-cell chemoattractant
, B-cell-attracting chemokine 1
, B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1)
, B-lymphocyte chemoattractant
, b cell-attracting chemokine 1
, b lymphocyte chemoattractant
, chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
, small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cell chemoattractant)